Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - CPI-0610 carboxylic acid

CPI-0610 carboxylic acid

CAS No. 1380089-81-5

CPI-0610 carboxylic acid( —— )

Catalog No. M32861 CAS No. 1380089-81-5

CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	673	In Stock
10MG	901	In Stock
25MG	1311	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CPI-0610 carboxylic acid
Note

Research use only, not for human use.
Brief Description

CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein.
Description

CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein. CPI-0610 carboxylic acid may have anticancer and anticancer activities.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Chromatin/Epigenetic
Target

Epigenetic Reader Domain
Recptor

Epigenetic Reader Domain | Ligands for Target Protein for PROTAC
Research Area

——
Indication

——

Chemical Information

CAS Number

1380089-81-5
Formula Weight

366.8
Molecular Formula

C20H15ClN2O3
Purity

>98% (HPLC)
Solubility

——
SMILES

CC=1C=2C=3C(C(=N[C@@H](CC(O)=O)C2ON1)C4=CC=C(Cl)C=C4)=CC=CC3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

PBRM1-BD2-IN-3

PBRM1-BD2-IN-3 (compound 12) is a potent PBRM1-BD2 inhibitor with an IC50 of 1.1 μM, used in anticancer research.
PBRM1-BD2-IN-7

PBRM1-BD2-IN-7, a selective and cell-active inhibitor targeting the polybromo-1 (PBRM1) bromodomain, demonstrates inhibitory efficacy against PBRM1-BD2 with an IC50 value of 0.29 μM.
AW68

AW68 is a potential small molecule BRD4 inhibitor that prevents and treats BRD4-related diseases and can be used in cancer research.

Sign In Join Free